fospropofol disodium

Phase 3Completed

0 views this week 0 watching⚡ Active

Interest: 40/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Angioplasty

Conditions

Angioplasty, Coronary Catheterization

Trial Timeline

Feb 1, 2004 → Mar 1, 2005

NCT ID

NCT00209547

About fospropofol disodium

fospropofol disodium is a phase 3 stage product being developed by Eisai for Angioplasty. The current trial status is completed. This product is registered under clinical trial identifier NCT00209547. Target conditions include Angioplasty, Coronary Catheterization.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (6)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00209599	Phase 2	Terminated	Feb 1, 2005	Mar 1, 2005	Colonoscopy
NCT00209560	Phase 3	Terminated	Oct 1, 2004	Mar 1, 2005	Arthroscopy
NCT00209573	Phase 3	Completed	Sep 1, 2004	Dec 1, 2004	Colonoscopy
NCT00209586	Phase 3	Terminated	Sep 1, 2004	Mar 1, 2005	Flexible Bronchoscopy
NCT00209547	Phase 3	Completed	Feb 1, 2004	Mar 1, 2005	Angioplasty
NCT00209534	Phase 2	Completed	Jan 1, 2003	Feb 1, 2004	Colonoscopy

Competing Products

1 competing product in Angioplasty

See all competitors

Product	Company	Stage	Hype Score
Otamixaban (XRP0673) + Unfractionated Heparin	Sanofi	Phase 2	35